Cerus Corporation

CERS ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $20.0M $20.3M $11.6M $35.6M $48.8M $36.6M $35.0M $28.9M
Accounts Receivable $30.4M $29.8M $35.5M $34.4M $25.1M $21.2M $16.9M $8.8M
Inventory $56.1M $38.2M $39.9M $29.0M $26.8M $23.3M $19.5M $13.5M
Total Current Assets $174.4M $152.0M $144.4M $170.1M $187.1M $183.4M $128.1M $146.9M
Property, Plant & Equipment $9.2M $7.2M $8.6M $11.0M $12.2M $13.9M $14.9M $8.1M
Goodwill $1.3M $1.3M $1.3M $1.3M $1.3M $1.3M $1.3M $1.3M
Intangible Assets (Excl. Goodwill) — — — — — — $132.0K $334.0K
Total Assets $221.9M $200.9M $197.7M $218.1M $237.5M $221.4M $165.5M $163.5M
Liabilities
Accounts Payable $28.0M $21.7M $23.8M $33.0M $35.6M $24.2M $22.2M $18.6M
Total Current Liabilities $100.8M $63.6M $67.5M $117.1M $78.6M $60.0M $50.3M $52.7M
Long-Term Debt — — — — — — — —
Total Liabilities $156.9M $144.0M $144.3M $149.5M $151.9M $117.6M $108.5M $78.9M
Stockholders' Equity
Retained Earnings $-1.08B $-1.07B $-1.04B $-1.01B $-964.3M $-910.0M $-850.1M $-778.9M
Total Stockholders' Equity $64.2M $56.1M $52.7M $67.6M $84.6M $103.8M $57.1M $84.5M
← Newer Page 1 of 2 Older →